Trial reportBMC psychiatry2026
Intensified return to work clinical aftercare for sick-listed employees with diagnosed mental disorders in Germany: effects of a multicentre randomized controlled trial.
Trial report in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMental disorders are a leading cause of sickness absence and disability in Europe. They often follow chronic or recurrent patterns, hindering a sustainable return to work (RTW). In Germany, RTW aftercare interventions focusing on maintaining recovery and minimizing relapse among employees transitioning from psychiatric treatment to the workplace are scarce. We therefore developed an intensified RTW clinical aftercare program (RTW-PIA). This study aimed to (i) evaluate the effectiveness of RTW-PIA in addition to Care as Usual (CAU) on achieving sustainable RTW (SRTW) compared to CAU only, (ii) assess its impact on secondary outcomes, and (iii) explore potential moderators.
methodsThis multicentre randomized controlled trial, conducted in psychiatric outpatient clinics, included sick-listed employees diagnosed with a mental disorder. Participants (N = 484) were randomized to RTW-PIA + CAU (n = 240) or CAU only (n = 244). RTW-PIA is an 18-month multimodal aftercare combining medical-psychotherapeutic and work-oriented components. Primary outcome was self-reported SRTW, defined as ≤ 6 weeks of sickness absence within 12 months after full RTW. Primary and secondary outcomes (e.g., RTW self-efficacy, work ability) were collected at baseline and at 6, 12, 18, and 24 months. Intention-to-treat analyses used logistic regression and growth curve models, complemented by prespecified sensitivity and exploratory moderator analyses.
resultsOverall, RTW-PIA had no significant effect on achieving SRTW (OR = 1.38 [95% CI 0.89 to 2.12]). Secondary outcomes revealed no significant effects, despite a consistent pattern of slight improvements favoring RTW-PIA. Per-protocol and complete-case sensitivity analyses led to the same conclusion. In diagnostic subgroup sensitivity analyses, employees with recurrent depressive disorders showed significant improvements in several secondary outcomes. Prespecified exploratory moderator analyses suggested potential benefits for employees without a recognized disability degree and for those with low social support at work. After multiplicity adjustment, only recurrent depressive disorder still moderated the treatment effect on work ability.
conclusionsOn average, RTW-PIA did not significantly improve SRTW or secondary outcomes. Employees without a recognized disability degree, with low social support at work, or with diagnosed recurrent depressive disorders might benefit from RTW-PIA. These hypotheses need to be tested in independent samples. Further research should also focus on the implementation of RTW-PIA.
trial registrationDRKS00026232 (prospectively registered on 01/09/2021).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.